Effect of baseline characteristics on mortality in the SURVIVE trial comparing levosimendan and dobutamine in acute heart failure: sub-analysis of the Finnish patients
23 May 2016 (08:30 - 18:00)
Organised by:
Abstract
About the speaker
Helsinki University Hospital, Helsinki (Finland)
29 More presentations in this session
Access the full session
The Event
HEART FAILURE 2016
23 May 2016
08:30 CET